Nectar Lifesciences Ltd. Company Cash Flow Statement & Analysis

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Profit Before Tax	-161.53	18.28	-40.69	34.35	-59.34
Net CashFlow-Operating Activity	169.44	224.69	133.37	95.04	21.33
Net Cash Used In Investing Activity	-41.93	-17.02	52.03	16.64	-28.62
NetCash Used in Fin. Activity	-128.09	-205.44	-185.57	-119.38	11.49
Net Inc/Dec In Cash And Equivlnt	-0.58	2.23	-0.17	-7.70	4.20
Cash And Equivalnt Begin of Year	19.80	17.57	17.74	25.43	21.23
Cash And Equivalnt End Of Year	19.22	19.80	17.57	17.74	25.43

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article